Literature DB >> 6429246

In vitro T cell-mediated killing of Pseudomonas aeruginosa. I. Evidence that a lymphokine mediates killing.

R B Markham, J Goellner, G B Pier.   

Abstract

Previous studies have demonstrated in vivo that T cells can provide protective immunity, in the absence of antibody, against infection with the extracellular Gram-negative bacterium Immunotype 1 (IT-1) Pseudomonas aeruginosa. We established an in vitro system in which immune T cells, after reexposure to bacterial antigens and to macrophages, secrete a product that kills the bacteria. Although macrophages are required for in vitro killing, they function neither as antigen-presenting nor as phagocytic cells in this system. T cells from animals immunized against a different P. aeruginosa immunotype will not kill IT-1 organisms; but the supernatants produced by IT-1 immune T cells after exposure to macrophages and IT-1 P. aeruginosa organisms are nonspecifically effective in killing unrelated bacteria. Because the supernatants from immune T cells lose their bactericidal properties upon minimal dilution, we conclude that if this mechanism is active in vivo, it must play a role in local immunity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429246

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  The NKG2D-activating receptor mediates pulmonary clearance of Pseudomonas aeruginosa.

Authors:  Michael T Borchers; Nathaniel L Harris; Scott C Wesselkamper; Shiping Zhang; Yi Chen; Lisa Young; Gee W Lau
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice.

Authors:  W G Powderly; G B Pier; R B Markham
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Mapping of the T-cell recognition sites of Pseudomonas aeruginosa PAK polar pili.

Authors:  W Smart; P A Sastry; W Paranchych; B Singh
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

4.  Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.

Authors:  S M Levitz; M P Dupont
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica.

Authors:  I B Autenrieth; A Tingle; A Reske-Kunz; J Heesemann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 6.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23

7.  A role for intestinal T lymphocytes in bronchus mucosal immunity.

Authors:  F J Wallace; A W Cripps; R L Clancy; A J Husband; C S Witt
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

8.  Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.

Authors:  Y Iizawa; T Nishi; M Kondo; K Tsuchiya; A Imada
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

9.  A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung.

Authors:  M L Dunkley; R L Clancy; A W Cripps
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

10.  Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans.

Authors:  S M Levitz; M P Dupont; E H Smail
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.